EvE Bio
Daniel Brown is a senior scientist with extensive experience in high-throughput screening for drug discovery projects. Daniel has worked at companies like xilis, Alcami Corporation, AMRI, and Eve Bio, specializing in assay development and screening techniques such as fluorescence-based assays, mass spectrometry, SPR, radioligand binding, and cell-based functional assays. Prior to their industry roles, Daniel completed their PhD in Biochemistry and Chemistry at Vanderbilt University, following a BS in Chemistry/Marine Science from the University of Miami.
This person is not in the org chart
EvE Bio
EvE Bio is a launch-stage nonprofit Focused Research Organization (FRO) in Durham, North Carolina. We aim to produce a first draft map of the pharmome (the union of the sets of all approved pharmaceuticals and the gene products with which they functionally interact, particularly including their unintended or currently unknown targets). Like all FROs, EvE is supported by philanthropists who share our vision, and as a nonprofit will release its data and its technologies into the public domain.